Medifast Inc (New York Stock Exchange:MED)
| Market Cap | 127.93M-18.6% |
| Revenue (ttm) | 316.93M-34.0% |
| Net Income | -25.60M-803.7% |
| EPS | -2.33-828.1% |
| Shares Out | 11.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Sep 18, 2023 |
| Volume | 34,210 |
| Open | 11.45 |
| Previous Close | 11.44 |
| Day's Range | 11.38 - 11.51 |
| 52-Week Range | 9.22 - 14.15 |
| Beta | 0.70 |
| Analysts | Hold |
| Price Target | 59.67(+418.64%) |
| Earnings Date | Nov 9, 2026 |
MEDIFAST INC has a live Insider Score.
Scored on 8 qualifying trades from 1 insider in the last 90 days.
About MED
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MED stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in MED holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MED's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MED Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MED Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Optavia Segment | $76.38M | 56.96% |
| Selling, marketing, and after sales support | $34.74M | 25.90% |
| Technology | $8.57M | 6.39% |
| Administrative and corporate support functions | $8.10M | 6.04% |
| Distribution | $4.50M | 3.35% |
| Equity compensation | $1.82M | 1.36% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MED patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MED from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MED
| ETF | Est. Holding Size |
|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | $4.43M |
| VTIVanguard Morningstar Total Stock Market ETF | $3.87M |
| SLYSPDR S&P 600 Small Cap ETF | $2.21M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $1.97M |
| FNDASchwab Fundamental U.S. Small Company Index ETF | $1.52M |
| SMLFiShares U.S. Small-Cap Equity Factor ETF | $1.41M |
Estimated from each fund’s disclosed top holdings × AUM
MED Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MED’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score